Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. (Record no. 9728383)

MARC details
000 -LEADER
fixed length control field 02337 a2200721 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513152922.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199811s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0006-4971
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name De Botton, S
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19981109
245 00 - TITLE STATEMENT
Title Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Blood
Date of publication, distribution, etc. Oct 1998
300 ## - PHYSICAL DESCRIPTION
Extent 2712-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Acute Kidney Injury
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cardiovascular Diseases
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytarabine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dexamethasone
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Incidence
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Promyelocytic, Acute
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukocyte Count
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Life Tables
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pericardial Effusion
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pleural Effusion
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Proportional Hazards Models
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Remission Induction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Respiration Disorders
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Syndrome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tretinoin
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dombret, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanz, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Miguel, J S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Caillot, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zittoun, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gardembas, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Stamatoulas, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Condé, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Guerci, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gardin, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Geiser, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Makhoul, D C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reman, O
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name de la Serna, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lefrere, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chomienne, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chastang, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Degos, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fenaux, P
773 0# - HOST ITEM ENTRY
Title Blood
Related parts vol. 92
-- no. 8
-- p. 2712-8

No items available.